General Information of the Compound
| Compound ID |
CP0430314
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-(4-octyl-3,5-dioxo-1,2,4-triazolidin-1-yl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H40N6O5S
|
||||||||||||||||||
| Molecular Weight |
608.765
|
||||||||||||||||||
| Canonical SMILES |
CCCCCCCCn1c(=O)[nH]n(-c2ccc(cc2)S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H40N6O5S/c1-2-3-4-5-6-7-21-36-30(39)34-37(31(36)40)27-14-16-28(17-15-27)43(41,42)35-26-12-10-24(11-13-26)18-20-33-23-29(38)25-9-8-19-32-22-25/h8-17,19,22,29,33,35,38H,2-7,18,20-21,23H2,1H3,(H,34,39)/t29-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
PWNRWNDSJIDVON-LJAQVGFWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor